The psychiatric risk gene BRD1 modulates mitochondrial bioenergetics by transcriptional regulation.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
08 08 2022
Historique:
received: 13 01 2022
accepted: 01 07 2022
revised: 24 06 2022
entrez: 8 8 2022
pubmed: 9 8 2022
medline: 11 8 2022
Statut: epublish

Résumé

Bromodomain containing 1 (BRD1) encodes an epigenetic regulator that controls the expression of genetic networks linked to mental illness. BRD1 is essential for normal brain development and its role in psychopathology has been demonstrated in genetic and preclinical studies. However, the neurobiology that bridges its molecular and neuropathological effects remains poorly explored. Here, using publicly available datasets, we find that BRD1 targets nuclear genes encoding mitochondrial proteins in cell lines and that modulation of BRD1 expression, irrespective of whether it is downregulation or upregulation of one or the other existing BRD1 isoforms (BRD1-L and BRD1-S), leads to distinct shifts in the expression profile of these genes. We further show that the expression of nuclear genes encoding mitochondrial proteins is negatively correlated with the expression of BRD1 mRNA during human brain development. In accordance, we identify the key gate-keeper of mitochondrial metabolism, Peroxisome proliferator-activated receptor (PPAR) among BRD1's co-transcription factors and provide evidence that BRD1 acts as a co-repressor of PPAR-mediated transcription. Lastly, when using quantitative PCR, mitochondria-targeted fluorescent probes, and the Seahorse XFe96 Analyzer, we demonstrate that modulation of BRD1 expression in cell lines alters mitochondrial physiology (mtDNA content and mitochondrial mass), metabolism (reducing power), and bioenergetics (among others, basal, maximal, and spare respiration) in an expression level- and isoform-dependent manner. Collectively, our data suggest that BRD1 is a transcriptional regulator of nuclear-encoded mitochondrial proteins and that disruption of BRD1's genomic actions alters mitochondrial functions. This may be the mechanism underlying the cellular and atrophic changes of neurons previously associated with BRD1 deficiency and suggests that mitochondrial dysfunction may be a possible link between genetic variation in BRD1 and psychopathology in humans.

Identifiants

pubmed: 35941107
doi: 10.1038/s41398-022-02053-2
pii: 10.1038/s41398-022-02053-2
pmc: PMC9359996
doi:

Substances chimiques

Mitochondrial Proteins 0
Peroxisome Proliferator-Activated Receptors 0
Protein Isoforms 0
BRD1 protein, human EC 2.3.1.48
Histone Acetyltransferases EC 2.3.1.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

319

Informations de copyright

© 2022. The Author(s).

Références

Biol Psychiatry. 2018 May 1;83(9):780-789
pubmed: 29628042
Clin Epigenetics. 2021 Jan 6;13(1):2
pubmed: 33407854
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Neurobiol Dis. 2019 Apr;124:479-488
pubmed: 30590179
Oncogene. 1999 Dec 9;18(52):7442-52
pubmed: 10602503
JAMA Psychiatry. 2021 Aug 1;78(8):911-921
pubmed: 34009292
World J Biol Psychiatry. 2011 Feb;12(1):48-56
pubmed: 20698738
JAMA Psychiatry. 2013 Jun;70(6):573-81
pubmed: 23894747
Cell. 2008 Jul 11;134(1):112-23
pubmed: 18614015
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Nat Neurosci. 2007 Jul;10(7):828-37
pubmed: 17529987
J Neurosci. 2019 May 1;39(18):3561-3581
pubmed: 30833507
J Neuropsychiatry Clin Neurosci. 2013 Fall;25(4):E27
pubmed: 24247879
Cell Stem Cell. 2017 Oct 5;21(4):533-546.e6
pubmed: 28985528
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Biol Psychiatry. 2005 Jul 15;58(2):85-96
pubmed: 16038679
Free Radic Biol Med. 2016 Nov;100:153-163
pubmed: 27352979
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Mol Psychiatry. 2015 Nov;20(11):1397-405
pubmed: 25560755
Nature. 1997 Jun 12;387(6634):733-6
pubmed: 9192902
Genes (Basel). 2022 Mar 17;13(3):
pubmed: 35328081
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
Curr Top Med Chem. 2012;12(6):486-504
pubmed: 22242852
Biol Psychiatry. 2017 Oct 15;82(8):594-600
pubmed: 28476208
Nat Rev Mol Cell Biol. 2018 Feb;19(2):77-92
pubmed: 28792006
Mol Psychiatry. 2004 Jul;9(7):684-97, 643
pubmed: 15098003
Schizophr Res. 2017 Sep;187:26-32
pubmed: 28526279
PLoS One. 2017 Jan 17;12(1):e0170121
pubmed: 28095495
Nucleic Acids Res. 2021 Jan 8;49(D1):D1541-D1547
pubmed: 33174596
Eur Neuropsychopharmacol. 2012 Sep;22(9):651-6
pubmed: 22341945
Mol Neuropsychiatry. 2015 Dec;1(4):201-19
pubmed: 26550561
Am J Med Genet. 2002 Mar 8;114(2):245-52
pubmed: 11857589
Genome Med. 2016 May 03;8(1):53
pubmed: 27142060
Exp Cell Res. 2016 Aug 1;346(1):30-9
pubmed: 27256846
Nucleic Acids Res. 2012 Jan;40(Database issue):D1016-22
pubmed: 22139918
Semin Cell Dev Biol. 2019 Nov;95:25-33
pubmed: 30529426
Schizophr Res. 2017 Sep;187:17-25
pubmed: 28189530
Transl Psychiatry. 2022 Jan 10;12(1):4
pubmed: 35013098
Mol Cell Biol. 2001 Mar;21(5):1747-58
pubmed: 11238912
Nature. 2014 Feb 13;506(7487):185-90
pubmed: 24463508
Am J Psychiatry. 2001 Dec;158(12):2048-55
pubmed: 11729024
Hum Mol Genet. 2005 Jan 15;14(2):241-53
pubmed: 15563509
Eur J Med Genet. 2020 Mar;63(3):103751
pubmed: 31465867
Mol Psychiatry. 2006 Dec;11(12):1126-38
pubmed: 16924267
Brain Res Bull. 2001 Jul 15;55(5):597-610
pubmed: 11576756
Mol Neurobiol. 2021 Sep;58(9):4495-4505
pubmed: 34056693
Sci Adv. 2019 Apr 17;5(4):eaav1472
pubmed: 31001581
Neurobiol Learn Mem. 2017 May;141:44-52
pubmed: 28341151
Nat Neurosci. 2015 Feb;18(2):199-209
pubmed: 25599223
Sci Adv. 2021 Dec 17;7(51):eabj9446
pubmed: 34910505
World Psychiatry. 2017 Jun;16(2):121-129
pubmed: 28498595
Nat Genet. 2018 Mar;50(3):381-389
pubmed: 29483656
Neurosci Lett. 2012 May 10;516(1):110-3
pubmed: 22675730
Mol Psychiatry. 2019 Mar;24(3):409-420
pubmed: 29317742
Sci Rep. 2016 Jan 29;6:19544
pubmed: 26822410
Nucleic Acids Res. 2016 Jan 4;44(D1):D1251-7
pubmed: 26450961
Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1130-7
pubmed: 20441769
Biol Psychiatry. 2018 May 1;83(9):739-750
pubmed: 29217297
Nat Neurosci. 2011 Jan;14(1):69-76
pubmed: 21151119
Biol Psychiatry. 2018 May 1;83(9):751-760
pubmed: 29486891
Eur Arch Psychiatry Clin Neurosci. 2017 Feb;267(1):3-17
pubmed: 27377417
JIMD Rep. 2016;27:17-26
pubmed: 26404456
Nat Rev Neurosci. 2012 Apr 18;13(5):293-307
pubmed: 22510887
Nature. 2014 Nov 13;515(7526):216-21
pubmed: 25363768
Front Behav Neurosci. 2018 Dec 06;12:306
pubmed: 30574076
Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):582-591
pubmed: 19693800
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Blood. 2011 Sep 1;118(9):2443-53
pubmed: 21753189
Neuron. 2019 Jun 19;102(6):1127-1142.e3
pubmed: 31079872
Sci Rep. 2017 May 8;7(1):1525
pubmed: 28484249
Biotech Histochem. 2005 May-Aug;80(3-4):133-7
pubmed: 16298898
Behav Brain Funct. 2018 Feb 20;14(1):4
pubmed: 29458409
Neuron. 2015 Feb 18;85(4):742-54
pubmed: 25695269
Neuroimage. 2021 Dec 1;244:118603
pubmed: 34560273
Biol Psychiatry. 2017 Jul 1;82(1):62-76
pubmed: 27837920
J Neurodev Disord. 2020 Feb 12;12(1):7
pubmed: 32050889
Can J Psychiatry. 2007 Dec;52(12):763-71
pubmed: 18186176
Schizophr Bull. 2014 Jan;40(1):13-7
pubmed: 24319118
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
Front Cell Neurosci. 2016 Feb 16;10:18
pubmed: 26909022
Transl Psychiatry. 2020 Jul 17;10(1):239
pubmed: 32681022
Brain Struct Funct. 2009 Dec;214(1):37-47
pubmed: 19763615
Ann Med. 2008;40(4):281-95
pubmed: 18428021
Mol Psychiatry. 2012 Mar;17(3):290-314
pubmed: 21263444
Nature. 2012 Apr 04;485(7397):237-41
pubmed: 22495306
Bipolar Disord. 2015 Nov;17(7):743-52
pubmed: 26477793
Biol Psychiatry. 2004 Apr 1;55(7):676-84
pubmed: 15038995
Mol Autism. 2012 Nov 01;3(1):12
pubmed: 23116158
Sci Rep. 2018 Nov 7;8(1):16486
pubmed: 30405140
Methods Mol Biol. 2017;1567:15-32
pubmed: 28276010
Nucleic Acids Res. 2012 Jan;40(Database issue):D1160-7
pubmed: 22121219
Nat Med. 2016 Jan;22(1):37-45
pubmed: 26642438

Auteurs

Veerle Paternoster (V)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.

Cagla Cömert (C)

Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Louise Sand Kirk (LS)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.

Sanne Hage la Cour (SH)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.

Tue Fryland (T)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.

Paula Fernandez-Guerra (P)

Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Magnus Stougaard (M)

Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Jens Randel Nyengaard (JR)

Core Center for Molecular Morphology, Section for Stereology and Microscopy, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Per Qvist (P)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark. per.q@biomed.au.dk.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark. per.q@biomed.au.dk.
Department of Biomedicine, Aarhus University, Aarhus, Denmark. per.q@biomed.au.dk.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark. per.q@biomed.au.dk.

Peter Bross (P)

Research Unit for Molecular Medicine, Department of Clinical Medicine, Aarhus University and Aarhus University Hospital, Aarhus, Denmark.

Anders Dupont Børglum (AD)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark.

Jane Hvarregaard Christensen (JH)

The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark. jhc@biomed.au.dk.
Centre for Integrative Sequencing, iSEQ, Aarhus University, Aarhus, Denmark. jhc@biomed.au.dk.
Department of Biomedicine, Aarhus University, Aarhus, Denmark. jhc@biomed.au.dk.
Center for Genomics and Personalized Medicine, CGPM, Aarhus University, Aarhus, Denmark. jhc@biomed.au.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH